A Multilevel, Multiphase Optimization Strategy for PrEP (MOST:PrEP)
Launched by HENRY FORD HEALTH SYSTEM · Mar 26, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Provider:≥ 18-years old
- • Provider: employed at HFH as a primary care provider
- • Provider: eligible to write prescriptions in the state of Michigan
- • Patient: ≥ 18 years old
- • Patient: have an appointment with a Henry Ford primary care clinic during the study period
- • Patient: have an EHR account
- • Patient: meet the indications for PrEP
- Exclusion Criteria:
- • Provider: not a HFH primary care provider
- • Provider: does not have prescribing privileges in the state of Michigan
- • Patient: currently prescribed or taking PrEP
- • Patient: living with HIV
About Henry Ford Health System
Henry Ford Health System is a comprehensive, nonprofit healthcare organization based in Detroit, Michigan, renowned for its commitment to advancing medical research and patient care. With a robust network of hospitals, outpatient facilities, and specialty clinics, Henry Ford Health System is dedicated to innovation in clinical trials, focusing on translating scientific discoveries into effective treatments. The organization emphasizes multidisciplinary collaboration, leveraging its extensive resources and expertise to address diverse health challenges. Through its clinical research initiatives, Henry Ford Health System aims to enhance patient outcomes and contribute to the advancement of medical knowledge on both a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Detroit, Michigan, United States
Patients applied
Trial Officials
Elizabeth Lockhart, PhD
Principal Investigator
Henry Ford Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported